Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering. | Commun Biol | 2022 | 35288635 | PubTator, text mining | PubMed |
| Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells. | Front Immunol | 2022 | 35281028 | PubTator, text mining | PubMed |
| An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models. | Front Immunol | 2022 | 35273608 | PubTator, text mining | PubMed |
| Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancer. | PLoS Comput Biol | 2022 | 35263321 | PubTator, text mining | PubMed |
| Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection. | PLoS One | 2022 | 35259162 | PubTator, text mining | PubMed |
| An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy. | Nat Cancer | 2022 | 35256819 | PubTator, text mining | PubMed |
| Circulating Memory B Cells in Early Multiple Sclerosis Exhibit Increased IgA+ Cells, Globally Decreased BAFF-R Expression and an EBV-Related IgM+ Cell Signature. | Front Immunol | 2022 | 35250986 | PubTator, text mining | PubMed |
| An antibody Fc engineered for conditional antibody-dependent cellular cytotoxicity at the low tumor microenvironment pH. | J Biol Chem | 2022 | 35248534 | PubTator, text mining | PubMed |
| Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies. | Cell Mol Life Sci | 2022 | 35244787 | PubTator, text mining | PubMed |
| Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques. | iScience | 2022 | 35243248 | PubTator, text mining | PubMed |
| Helicobacter pylori infection manifesting as Hypereosinophilic syndrome and immune thrombocytopenia complicated by portal vein thrombosis and ischemic colitis. | IDCases | 2022 | 35242558 | PubTator, text mining | PubMed |
| ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern. | Antiviral Res | 2022 | 35240221 | PubTator, text mining | PubMed |
| Establishment of fetomaternal tolerance through glycan-mediated B cell suppression. | Nature | 2022 | 35236989 | PubTator, text mining | PubMed |
| A novel mouse strain optimized for chronic human antibody administration. | Proc Natl Acad Sci U S A | 2022 | 35235456 | PubTator, text mining | PubMed |
| The Role of Bispecific Antibodies in Non-Hodgkin's Lymphoma: From Structure to Prospective Clinical Use. | Antibodies (Basel) | 2022 | 35225874 | PubTator, text mining | PubMed |
| Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. | Front Immunol | 2022 | 35222423 | PubTator, text mining | PubMed |
| A B-cell or a key player? The different roles of B-cells and antibodies in melanoma. | Pigment Cell Melanoma Res | 2022 | 35218154 | PubTator, text mining | PubMed |
| Tumor-specific T cells support chemokine-driven spatial organization of intratumoral immune microaggregates needed for long survival. | J Immunother Cancer | 2022 | 35217577 | PubTator, text mining | PubMed |
| The Role of Innate Immunity in Natural Elite Controllers of HIV-1 Infection. | Front Immunol | 2022 | 35211115 | PubTator, text mining | PubMed |
| Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms. | Medicina (Kaunas) | 2022 | 35208534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=51